Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 7
Submit an article Journal homepage
2,892
Views
5
CrossRef citations to date
0
Altmetric
Commentary

Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

Tarun Salujaa International Vaccine Institute, Seoul, Republic of KoreaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9771-7021View further author information
ORCID Icon,
Bishnu Rath Girib Kanti Children’s Hospital, Kathmandu, NepalORCID Iconhttps://orcid.org/0000-0001-5238-2061View further author information
ORCID Icon,
Shipra Chaudharyc B P Koirala Institute of Health Sciences, Dharan, NepalView further author information
,
Dipesh Tamrakard Kathmandu University School of Medical Sciences, Dhulikhel, NepalView further author information
,
Piush Kanodiae Nepalgunj Medical College, Nepalgunj, NepalView further author information
,
Sonali Palkarf Bharti Hospital, Pune, IndiaView further author information
,
Sridhar Vemulaa International Vaccine Institute, Seoul, Republic of KoreaView further author information
,
Suchada Chinaworaponga International Vaccine Institute, Seoul, Republic of KoreaView further author information
,
Bomi Kima International Vaccine Institute, Seoul, Republic of KoreaView further author information
,
Birendra Prasad Guptaa International Vaccine Institute, Seoul, Republic of KoreaView further author information
,
Sue Kyoung Joa International Vaccine Institute, Seoul, Republic of KoreaView further author information
,
Sanet Aspinallg Ardent Consulting (Pty) Ltd, South AfricaView further author information
,
Ganesh Kumar Raib Kanti Children’s Hospital, Kathmandu, NepalView further author information
,
Duncan Steeleh Bill & Melinda Gates Foundation, Seattle, USAView further author information
,
Jerome H. Kima International Vaccine Institute, Seoul, Republic of KoreaORCID Iconhttps://orcid.org/0000-0003-0461-6438View further author information
ORCID Icon,
T. Anh Wartela International Vaccine Institute, Seoul, Republic of KoreaView further author information
&
Sushant Sahastrabuddhea International Vaccine Institute, Seoul, Republic of KoreaView further author information
 show all
Pages 2149-2157 | Received 08 Sep 2020, Accepted 20 Nov 2020, Published online: 01 Feb 2021

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.